Literature DB >> 35061143

Involvement of ischemia-driven 5-lipoxygenase-resolvin-E1-chemokine like receptor-1 axis in the resolution of post-coronary artery bypass graft inflammation in coronary arteries.

Finosh G Thankam1, Victoria E D Wilson2, Mohamed M Radwan1, Aleem Siddique3, Devendra K Agrawal4.   

Abstract

AIMS: Expression status of pro-resolvin lipid mediators (PLM) and receptors in the post-Coronary artery bypass grafting (CABG) coronary arteries are largely unknown. Here, we aim to investigate the expression of the enzymes involved in PLM synthesis and their receptors in the atherosclerotic post-CABG swine (AS) left anterior descending (LAD) compared to without CABG (LAD-AS), and in isolated coronary artery smooth muscle cells (CASMCs) cultured under ischemia.
METHODOLOGY: The arteries of interest were harvested from post-CABG atherosclerotic swine and the histomorphology and the expression status of key PLM mediators were quantified using immunostaining. Smooth muscle cells (SMCs) were cultured under ischemia and confirmed the expression on PLM mediators at transcript and protein level.
RESULTS: The histomorphometric analysis revealed considerable alterations in the tissue architecture in LAD-CABG and LAD-AS arteries compared to control. PLM synthetic enzyme 5-lipoxygenases (5LO) was significantly upregulated in LAD-CABG and LAD-AS whereas the other enzymes including 12LO, 15LO, and cyclooxygenase-2, and the receptors including Chemokine like receptor 1 (ChemR23), 7-transmembrane G-protein coupled receptor-18 (GPCR18), GPCR120 were decreased in LAD-CABG than control. LO enzymes and PLM receptors were upregulated in ischemic CASMCs with respect to control. Western blot showed the upregulation of 5LO, and ChemR23. Additionally, higher level of resolvin-E1 (RvE1) was observed in ischemic control CASMCs which was decreased following reperfusion.
CONCLUSION: These findings suggest that the CASMCs withstand the ischemia-triggered proinflammatory episodes by increasing the secretion of RvE1 mediated through 5LO and ChemR23 signaling.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Coronary artery bypass grafting; Ischemia; Ischemic heart diseases; Lipoxygenases; Pro-resolvin mediators; Reperfusion

Mesh:

Substances:

Year:  2022        PMID: 35061143     DOI: 10.1007/s11033-022-07143-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  29 in total

1.  Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.

Authors:  Vasundhara Kain; Kevin A Ingle; Romain A Colas; Jesmond Dalli; Sumanth D Prabhu; Charles N Serhan; Medha Joshi; Ganesh V Halade
Journal:  J Mol Cell Cardiol       Date:  2015-04-11       Impact factor: 5.000

Review 2.  Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.

Authors:  Brian E Sansbury; Matthew Spite
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

Review 3.  Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction.

Authors:  Vasundhara Kain; Sumanth D Prabhu; Ganesh V Halade
Journal:  Basic Res Cardiol       Date:  2014-09-24       Impact factor: 17.165

4.  Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.

Authors:  Anne E Barden; Emilie Mas; Kevin D Croft; Michael Phillips; Trevor A Mori
Journal:  Am J Clin Nutr       Date:  2015-11-11       Impact factor: 7.045

5.  Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.

Authors:  Madhur P Motwani; Romain A Colas; Marc J George; Julia D Flint; Jesmond Dalli; Angela Richard-Loendt; Roel Ph De Maeyer; Charles N Serhan; Derek W Gilroy
Journal:  JCI Insight       Date:  2018-03-22

Review 6.  Pro-Resolving Mediators in Regulating and Conferring Macrophage Function.

Authors:  Jesmond Dalli; Charles N Serhan
Journal:  Front Immunol       Date:  2017-11-01       Impact factor: 7.561

Review 7.  Pro-resolving lipid mediators in vascular disease.

Authors:  Michael S Conte; Tejal A Desai; Bian Wu; Melinda Schaller; Evan Werlin
Journal:  J Clin Invest       Date:  2018-08-31       Impact factor: 14.808

8.  Association of hypoxia and mitochondrial damage associated molecular patterns in the pathogenesis of vein graft failure: a pilot study.

Authors:  Finosh G Thankam; Joseph G Ayoub; Mohamed M Radwan Ahmed; Aleem Siddique; Thomas C Sanchez; Rafael A Peralta; Thomas J Pennington; Devendra K Agrawal
Journal:  Transl Res       Date:  2020-08-28       Impact factor: 7.012

9.  Molecular and Cellular Differences in Cardiac Repair of Male and Female Mice.

Authors:  Amanda B Pullen; Vasundhara Kain; Charles N Serhan; Ganesh V Halade
Journal:  J Am Heart Assoc       Date:  2020-04-16       Impact factor: 5.501

Review 10.  Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease.

Authors:  John Pirault; Magnus Bäck
Journal:  Front Pharmacol       Date:  2018-11-14       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.